This compound is a broad-spectrum anthelmintic effective against hookworm, ascariasis, and whipworm infections, with the best efficacy against hookworm, surpassing that of tetrachloroethylene and bromosaligenin. It acts as a B-type acetylcholine receptor (B-type AChR) agonist. However, due to poor intestinal absorption, low oral toxicity, and frequent gastrointestinal adverse effects (e.g., nausea, vomiting, abdominal pain, diarrhea), along with the availability of safer alternatives such as mebendazole and pyrantel, its clinical use has been largely discontinued. It was formerly used for the treatment of hookworm infection but is now obsolete and was listed among the 127 drugs phased out by the Chinese Ministry of Health in 1982.